MODERN DIAGNOSIS AND THERAPEUTIC BEHAVIOR IN THE TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA IN DIFFERENT TREATMENT CENTERS
Keywords:
primary open-angle glaucoma, intraocular pressure, diagnosis, treatmentAbstract
Glaucoma is one of the leading causes of blindness worldwide. Despite the many studies, this disease is a challenge for ophthalmologists with its unclear etiopathogenesis, many factors favoring its occurrence, difficult diagnosis and treatment. The aim of the present study is to make a comparative analysis of the methods of diagnosis and treatment in different treatment centers in outpatient and inpatient care. Material and methods: The object of the study are 302 patients diagnosed with "Primary Glaucoma" who have been treated at the Eye Hospital - Varna. To achieve the objectives of the study we used our own questionnaire to assess risk factors in patients with primary glaucoma, which includes: demographics, ophthalmic history, ocular status to: primary diagnosis, the beginning of follow-up at the Eye Hospital - Varna and now. The results were processed with SPSS v. 20.0 using variational, dispersion and comparative analyzes. Results: The average age of the studied patients is 65.8 years (29-96 years), women predominate, and the ratio of men: women is approximately 1:2. The diagnosis of POAG in most cases is made only on the basis of high IOP measurements. Although in the three examined medical establishments the medical treatment prevails. Laser treatment is most often used in specialized hospitals, surgical treatment in specialized eye clinics, and combination therapy in DCC. Conclusions: The treatment of patients with POAG reveals the main shortcoming of our social and health system, which shows that solvent patients have quick access to highly specialized care, the ability to early and effective diagnosis of glaucoma, and the use of modern medicine in treatment.
References
Anhchuong, L., Bickol, N.M., Catherine, A.M., & Hugh, R.T. (2003). Risk factors associated with the incidence of open-angle glaucoma: The Visual Impairment Project, Ivest Ophthalmol & Vis Science; 44 (9): 3783-9
Berdahl, J.P., Khatana, A.K., Katz, L.J., Herndon, L., Layton, A.J., Yu, T.M., et al. (2017). Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma. J Med Econ.;20:760–6
Bourne, R.R., Stevens, G.A., White, R.A., et al. (2013). Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Glob Health;1:e339–49
Cedrone, C., Maurino, R., Cerulli, A., Cesareo, M., & Nucci, C. (2008). Epidemiology of primary glaucoma: Prevalence incidence and blindy effects Prog Brain Res; 173:3-14
Garg, A., & Gazzard, G. (2020). Treatment choices for newly diagnosed primary open angle and ocular hypertension patients. Eye 34, 60–71
Gazzard, G., Konstantakopoulou, E., Garway-Heath, D., Garg, A., Vickerstaff, V., Hunter , R., et al. (2019). Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. (London, England).;393:1505–16
Goldberg, I., Clement, C.I., Chiang, T.H., et al. (2009). Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire. J Glaucoma;18:6-12
Jonas, J.B., Aung, T., Bourne, R.R., Bron, A.M., Ritch, R., & Panda-Jonas, S. (2017). Glaucoma. Lancet. Nov 11;390(10108):2183-2193
Kooner, K.S., AlBdoor, M., Cho, B.J., & Adams-Huet, B. (2008). Risk factors for progression to blindness in high tension primary open angle glaucoma: Comparison of blind and nonblind subjects. Clin Ophthalmol; 2:757–62
Leung, C.K., Cheung, C.Y., Weinreb, R.N., Qiu, K., Liu, S., Li, H., et al. (2010). Evaluation of Retinal Nerve Fiber Layer Progression in Glaucoma with Optical Coherence Tomography Guided Progression Analysis (Gpa) Invest Ophthalmol Vis Sci.;51:217–22
Rao, H.L., Addepalli, U.K., Jonnadula, G.B., et al. (2013). Relationship between intraocular pressure and rate of visual field progression in treated glaucoma. J Glaucoma;22:719–24
Rizzo, M.I., Greco, A., De Virgilio, A., Gallo, A., Taverniti, L., Fusconi, M., Conte, M., Pagliuca, G., Turchetta, R., & de Vincentiis, M. (2017). Glaucoma: recent advances in the involvement of autoimmunity. Immunol Res.;65(1):207–217
Rodriguez-Una, I., & Azuara-Blanco, A. (2018). New Technologies for Glaucoma Detection. Asia Pac J Ophthalmol (Phila). Nov-Dec;7(6):394-404
